ProCE Banner Activity

Equitable Care Delivery in Gynecologic Cancers: Patient and HCP Survey Results

Clinical Thought

Shannon N. Westin, MD, MPH, shares her takeaways from a patient preference survey administered to patients with gynecologic cancers covering topics such as cancer biomarkers guiding therapy and equitable delivery of gynecologic cancer care.

Released: March 08, 2023

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Eisai

GSK

Karyopharm Therapeutics Inc.

Merck Sharp & Dohme, LLC

Seagen and Genmab

Partners

Smart Patients

ProCE Banner

Disclosure

Shannon N. Westin, MD, MPH: consultant/advisor/speaker: AstraZeneca, Caris, Clovis, Eisai, EQRX, Genentech/Roche, GlaxoSmithKline, ImmunoGen, Lilly, Merck, Mereo, Mersana, NGM Bio, Nuvectis, Seagen, Verastem, Vincerx, Zentalis; researcher: AstraZeneca, AvengeBio, Bayer, Bio-Path, Clovis, Genentech/Roche, GlaxoSmithKline, Mereo, Novartis, Zentalis.